Additionally, in intrahepatic cholangiocarcinoma (ICC), the upregulation of nuclear factor of activated T cells 5 (NFAT5) increases GLUT1 expression and induces gemcitabine (GEM) resistance (Gao et al. 2023). Here, SLC2A1 is linked to intrahepatic cholangiocarcinoma.